Asia Pulp & Paper (APP) has said its future tissue investment strategy will be “heavy and mostly organic” and focused mostly on China and South East Asia.
In an interview with TW in Jakarta, Indonesia, APP director Hoany Muljadi told TW that the company’s tissue investment strategy is clear.
“If we want to enter this market even further we need to educate the consumer about why they need the tissue product. And we need heavy investment, which will mostly be organic. That’s our number one strategy.”
In total, APP’s Indonesian sites produce 0.5 million tonnes of tissue per year. Muljadi added: “In Indonesia, we have the number one position. We’re not number one in China, but we do have a significant market share in countries such as Singapore.
“Our challenge is to expand and make unique and personalised products.”
She added that there’s “huge potential” for the tissue market in China and South East Asia, adding
“the tissue market is expanding very rapidly”.
For a full write-up of TW’s visit to APP in Indonesia, see the April/May issue of the magazine.